Steering and coordination
As part of the Finnish Cancer Center, the national cancer screening steering group provides guidance and monitors the initiation, implementation, and development of cancer screenings. The steering group makes recommendations and offers expertise to the Ministry of Social Affairs and Health in the preparation of laws and regulations related to cancer screenings. Additionally, the steering group has appointed expert groups for each cancer screening program to provide more detailed instructions on the implementation of screenings.
National cancer screening steering group
- Annika Auranen, chair, FICAN Mid, Tampere Univesrity Hospital (firstname.lastname@pirha.fi)
- Jussi Koivunen, FICAN North, Oulu University Hospital
- Mika Mustonen, FICAN South, Helsinki University Hospital
- Pia Vihinen, FICAN West, Turku University Hospital
- Satu Tiainen, FICAN East, Kuopio Universtity Hospital
- Timo Nykopp, FICAN Coordinating unit, Helsinki University Hospital)
- Vesa Kataja, The wellbeing services county of South Savo
- Vesa Jormanainen, Ministry of Social Affairs and Health, STM
Cancer screening expert groups
- Cervical cancer screening group, chair Pekka Nieminen (firstname.lastname@hus.fi)
- Breast cancer screening group, chair Johanna Alanko (firstname.lastname@terveystalo.fi)
- Colorectal cancer screening group, chair Tytti Sarkeala (firstname.lastname@cancer.fi)
- Prostate cancer screening group (feasibility study), chair Anssi Auvinen (firstname.lastname@tuni.fi)
- Lung cancer screening group (feasibility study), chair Jussi Koivunen (firstname.lastname@pohde.fi)
Cancer screening quality manuals
The quality manuals for cancer screenings are intended to support decision-making and operations for those responsible for organizing and practically implementing screening. The manuals provide recommendations based on research and practical experience for implementing effective and cost-effective screening programs.
The quality manuals provide detailed guidance on the various stages of a screening program, from sending invitations to follow-up screenings and reporting screening data to the National Cancer Registry.
